[HTML][HTML] Clinical validity and utility of genetic risk scores in prostate cancer
Current issues related to prostate cancer (PCa) clinical care (eg, over-screening, over-
diagnosis, and over-treatment of nonaggressive PCa) call for risk assessment tools that can …
diagnosis, and over-treatment of nonaggressive PCa) call for risk assessment tools that can …
Clinical validity and utility of genetic risk scores in prostate cancer
BT Helfand, J Kearns, C Conran… - Asian journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Current issues related to prostate cancer (PCa) clinical care (eg, over-screening, over-
diagnosis, and over-treatment of nonaggressive PCa) call for risk assessment tools that can …
diagnosis, and over-treatment of nonaggressive PCa) call for risk assessment tools that can …
[HTML][HTML] Clinical validity and utility of genetic risk scores in prostate cancer
BT Helfand, J Kearns, C Conran, J Xu - Asian Journal of Andrology, 2016 - ncbi.nlm.nih.gov
Current issues related to prostate cancer (PCa) clinical care (eg, over-screening, over-
diagnosis, and over-treatment of nonaggressive PCa) call for risk assessment tools that can …
diagnosis, and over-treatment of nonaggressive PCa) call for risk assessment tools that can …
Clinical validity and utility of genetic risk scores in prostate cancer
B HELFAND - Asian Journal of Andrology, 2016 - pesquisa.bvsalud.org
Current issues related to prostate cancer (PCa) clinical care (eg, over-screening, over-
diagnosis, and over-treatment of nonaggressive PCa) call for risk assessment tools that can …
diagnosis, and over-treatment of nonaggressive PCa) call for risk assessment tools that can …
Clinical validity and utility of genetic risk scores in prostate cancer.
BT Helfand, J Kearns, C Conran, J Xu - Asian Journal of Andrology, 2016 - europepmc.org
Current issues related to prostate cancer (PCa) clinical care (eg, over-screening, over-
diagnosis, and over-treatment of nonaggressive PCa) call for risk assessment tools that can …
diagnosis, and over-treatment of nonaggressive PCa) call for risk assessment tools that can …
Clinical validity and utility of genetic risk scores in prostate cancer
B Helfand, J Kearns, C Conran, J Xu - Asian Journal of Andrology, 2016 - go.gale.com
Current issues related to prostate cancer (PCa) clinical care (eg, over-screening, over-
diagnosis, and over-treatment of nonaggressive PCa) call for risk assessment tools that can …
diagnosis, and over-treatment of nonaggressive PCa) call for risk assessment tools that can …
Clinical validity and utility of genetic risk scores in prostate cancer.
BT Helfand, J Kearns, C Conran… - Asian Journal of …, 2016 - search.ebscohost.com
Current issues related to prostate cancer (PCa) clinical care (eg, over-screening, over-
diagnosis, and over-treatment of nonaggressive PCa) call for risk assessment tools that can …
diagnosis, and over-treatment of nonaggressive PCa) call for risk assessment tools that can …
Clinical validity and utility of genetic risk scores in prostate cancer.
BT Helfand, J Kearns, C Conran, XJF Xu JianFeng - 2016 - cabidigitallibrary.org
Current issues related to prostate cancer (PCa) clinical care (eg, over-screening, over-
diagnosis, and over-treatment of nonaggressive PCa) call for risk assessment tools that can …
diagnosis, and over-treatment of nonaggressive PCa) call for risk assessment tools that can …
Clinical validity and utility of genetic risk scores in prostate cancer.
BT Helfand, J Kearns, C Conran, J Xu - Asian Journal of Andrology, 2016 - europepmc.org
Current issues related to prostate cancer (PCa) clinical care (eg, over-screening, over-
diagnosis, and over-treatment of nonaggressive PCa) call for risk assessment tools that can …
diagnosis, and over-treatment of nonaggressive PCa) call for risk assessment tools that can …